Clinical Characteristics | Unidentified group I | rotavirus group II | E. histolytica group III | adenovirus group IV | Mixed group V | Total | P-value |
---|---|---|---|---|---|---|---|
Frequency (%) | 287 (46.4%) | 84 (13.6%) | 172 (27.8%) | 38 (6.1%) | 38 (6.1%) | 619 | – |
Clinical Manifestations | |||||||
 Fever | 215 (74.9%) | 52 (61.9%) | 143 (83.1%) | 22 (57.9%) | 26 (68.4%) | 458 | 0.001 |
 Vomiting | 112 (39.0%) | 53 (63.1%) | 66 (38.4%) | 22 (57.9%) | 24 (63.2%) | 277 | 0.000 |
 Diarrhea | 208 (72.5%) | 69 (82.1%) | 144 (83.7%) | 33 (86.8%) | 29 (76.3%) | 483 | 0.016 |
 Vesikari score (Mean ± SD) | 11.2 ± 1.8 | 11.4 ± 1.5 | 11.8 ± 1.6 | 11.2 ± 1.6 | 11.3 ± 1.8 | – | 0.005 |
 Duration of hospitalization per days (Mean ± SD) | 2.7 ± 1.2 | 2.9 ± 1.1 | 2.9 ± 1.2 | 3.3 ± 2.1 | 3.4 ± 1.3 | 3.04a | 0.003 |
Laboratory Findings | |||||||
 WBCs (× 103 per mm3) | 2.79 ± 3.85 | 2.29 ± 3.04 | 12.23 ± 4.98 | 1.92 ± 2.29 | 7.15 ± 6.76 | – | 0.000 |
 RBCs (million per mm3) | 1.47 ± 1.88 | 1.53 ± 2.06 | 7.10 ± 5.45 | 1.14 ± 1.01 | 3.19 ± 3.99 | – | 0.000 |
 HGB (in mg/dL; mean ± SD) | 11.7 ± 2.4 | 11.5 ± 1.2 | 12.6 ± 8.4 | 12.1 ± 1.0 | 11.5 ± 1.1 | – | 0.008 |
 HCT (in %; mean ± SD) | 33.5 ± 4.1 | 33.9 ± 3.2 | 34.0 ± 4.2 | 34.8 ± 4.7 | 34.1 ± 2.9 | – | 0.027 |
 BS (in mg/dL; mean ± SD) | 91.1 ± 28.3 | 77.1 ± 20.1 | 97.5 ± 19.2 | 86.0 ± 27.7 | 87.3 ± 19.1 | – | 0.000 |
 CRP (in mg/dL; mean ± SD) | 49.5 ± 65.9 | 28.0 ± 61.4 | 66.3 ± 67.4 | 11.7 ± 20.0 | 43.7 ± 85.9 | – | 0.000 |